MGMT and serous adenocarcinoma: We observed that complete methylation of MGMT was present in endometrioid (60%, 18/30), mucinous (33%, 10/30), and germ cell (86%, 6/7) subtypes, but almost absent in serous carcinoma (3%, 1/35).